Published in J Clin Endocrinol Metab on September 01, 2010
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. J Clin Endocrinol Metab (2011) 1.86
Diagnostic Value of Urinary Steroid Profiling in the Evaluation of Adrenal Tumors. Horm Cancer (2015) 1.40
Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin. Am J Pathol (2012) 1.23
Cushing's syndrome: epidemiology and developments in disease management. Clin Epidemiol (2015) 1.02
Current concepts in the management of adrenal incidentalomas. Urol Ann (2012) 0.89
Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia. Compr Physiol (2014) 0.88
Single nucleotide polymorphism array profiling of adrenocortical tumors--evidence for an adenoma carcinoma sequence? PLoS One (2013) 0.88
Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein corticosteroids before and after adrenocorticotropic hormone stimulation. Clin Endocrinol (Oxf) (2012) 0.83
Adrenal tumors with unexpected outcome: a review of the literature. Int J Endocrinol (2015) 0.83
Correlation between CT perfusion parameters and microvessel density and vascular endothelial growth factor in adrenal tumors. PLoS One (2013) 0.82
Improving patient notification of solid abdominal viscera incidental findings with a standardized protocol. J Trauma Manag Outcomes (2015) 0.77
Idiopathic adrenal hematoma masquerading as neoplasm. Case Rep Gastroenterol (2012) 0.76
Cystic adrenal lesions: focus on pediatric population (a review). Clujul Med (2017) 0.75
Adrenal Diagnostics: An Endocrinologist's Perspective focused on Hyperaldosteronism. Clin Biochem Rev (2013) 0.75
A 5-Year Prospective Follow-Up Study of Lipid-Rich Adrenal Incidentalomas: No Tumor Growth or Development of Hormonal Hypersecretion. Endocrinol Metab (Seoul) (2015) 0.75
Idiopathic adrenal hematoma mimicking neoplasia: A case report. Int J Surg Case Rep (2016) 0.75
Adrenal tumours: how to establish malignancy. BMJ Case Rep (2014) 0.75
How to approach and follow adrenal incidentaloma? Korean J Intern Med (2013) 0.75
Pure aldosterone-secreting adrenocortical carcinoma in a patient with refractory primary hyperaldosteronism. Endocrinol Diabetes Metab Case Rep (2015) 0.75
A Retroperitoneal Leiomyosarcoma Presenting as an Adrenal Incidentaloma in a Subject on Warfarin. Case Rep Endocrinol (2015) 0.75
Patient-specific workup of adrenal incidentalomas. Eur J Radiol Open (2017) 0.75
Screening for primary aldosteronism using the newly developed IDS-iSYS® automated assay system. Pract Lab Med (2016) 0.75
Clinical Guidelines for the Management of Adrenal Incidentaloma. Endocrinol Metab (Seoul) (2017) 0.75
Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2008) 6.48
Clinical practice. The incidentally discovered adrenal mass. N Engl J Med (2007) 5.33
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2008) 4.90
Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med (2003) 4.48
Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab (2007) 3.25
A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab (2000) 2.67
Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest (2006) 2.53
Incidentally discovered adrenal masses. Endocr Rev (1995) 2.40
Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology (2008) 2.27
Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab (2000) 1.99
Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am (2000) 1.81
Adrenal incidentaloma--experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med (2002) 1.74
Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study. Clin Endocrinol (Oxf) (2009) 1.67
Laparoscopic adrenalectomy. Best Pract Res Clin Endocrinol Metab (2006) 1.51
Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology (2000) 1.50
Incidentally discovered adrenal tumors: an institutional perspective. Surgery (1991) 1.43
Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? Eur J Endocrinol (2009) 1.37
Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience. J Clin Endocrinol Metab (2004) 1.34
Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Endocrinol Metab (1998) 1.34
Computed tomography in the diagnosis of adrenal disease. AJR Am J Roentgenol (1979) 1.32
Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol (Oxf) (1997) 1.24
The optimal imaging of adrenal tumours: a comparison of different methods. Endocr Relat Cancer (2007) 1.19
Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Ann Surg (2009) 1.19
Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J Clin Endocrinol Metab (1992) 1.15
Needle biopsy of incidentally discovered adrenal masses is rarely informative and potentially hazardous. Surgery (2007) 1.13
[11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings. J Clin Endocrinol Metab (2006) 1.11
Subclinical Cushing's syndrome in adrenal incidentalomas. Endocrinol Metab Clin North Am (2005) 1.02
Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. Eur J Endocrinol (2009) 1.02
Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. J Clin Endocrinol Metab (2001) 1.00
Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism. Rev Endocr Metab Disord (2007) 1.00
Clinical study of adrenal incidentaloma in Korea. Korean J Intern Med (2005) 0.98
Adrenal incidentaloma - follow-up results from a Swedish prospective study. Eur J Endocrinol (2006) 0.98
Surgical management of adrenal cysts: single-institution experience. BJU Int (2009) 0.98
Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes. Endocr J (2003) 0.97
"Subclinical Cushing's syndrome" is not subclinical: improvement after adrenalectomy in 9 patients. Surgery (2007) 0.96
Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group. Horm Res (1997) 0.94
Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients. J Clin Endocrinol Metab (2008) 0.93
The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. Eur J Endocrinol (2008) 0.92
Laparoscopic adrenalectomy for adrenal myelolipoma. Arch Esp Urol (2007) 0.92
Change in adrenal mass size as a predictor of a malignant tumor. Endocr Pract (2010) 0.91
Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery. World J Surg (2006) 0.89
Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery? Eur J Endocrinol (2009) 0.88
The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin Endocrinol (Oxf) (2001) 0.86
Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing's syndrome. Endocr J (2008) 0.85
Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study. Eur J Endocrinol (2009) 0.84
Frequency of pheochromocytoma in adrenal incidentalomas and utility of the glucagon test for the diagnosis. J Endocrinol Invest (1997) 0.80
Discrepancies in results of low-and high-dose dexamethasone suppression tests for diagnosing preclinical Cushing's syndrome. Endocr J (2005) 0.79
Prospective evaluation of tumor size and hormonal status in adrenal incidentalomas. J Endocrinol Invest (2009) 0.79
Late-night salivary cortisol as a screening test for the diagnosis of Cushing's syndrome in Japan. Endocr J (2008) 0.77